Amgen Inc. (AMGN) Stock Investment Calculator & Historical Return Analysis

Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Investors often view Amgen Inc. as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.

This Amgen Inc. stock investment calculator allows you to explore how a hypothetical investment in AMGN might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.

What if you invested $1000 in AMGN on Jan 1, 2020?

Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.

📈
Your investment journey awaits!
Click "Calculate Investment" to see your potential returns
Current Value
$XX,XXX
Return
+XXX%
CAGR
X.XX%
vs SPY
+XX%

Understanding Amgen Inc.'s Historical Performance

Amgen Inc.'s stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, AMGN has experienced periods of growth driven by innovation and market demand.

When analyzing Amgen Inc.'s historical returns, it's important to consider:

  • Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
  • Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
  • Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations. Try our calculator to explore returns over 5 years or larger investments over 10 years.

This calculator helps you see how these factors might have affected an investment depending on when you entered the market.

Historical Annual Returns

Over the past 40 years, Amgen Inc. has delivered an average annual return of 27.3%. The stock peaked in 1991 with a massive +256.5% gain, while investors faced a downturn in 2007 (-32.1%). Overall, the stock finished in the green 27 times out of 40 years.

Avg Return

+27.3%

Win Rate

68%

27W - 13L

Best

+256.5%

1991

Worst

-32.1%

2007

Performance Consistency

27 Positive13 Negative

Amgen Inc. Annual Returns by Year

YearAnnual ReturnStart PriceEnd Price
1986+74.26%$0.18$0.31
1987+31.22%$0.34$0.44
1988+4.65%$0.46$0.48
1989+53.12%$0.46$0.70
1990+141.75%$0.74$1.78
1991+256.47%$1.82$6.49
1992-5.52%$6.41$6.06
1993-29.91%$6.06$4.24
1994+20.10%$4.21$5.06
1995+103.86%$4.99$10.18
1996-6.65%$9.99$9.32
1997-0.92%$9.37$9.28
1998+93.86%$9.25$17.93
1999+123.75%$18.41$41.20
2000+1.59%$43.17$43.86
2001-10.23%$43.13$38.71
2002-14.29%$38.69$33.16
2003+25.28%$33.83$42.38
2004+2.89%$42.77$44.00
2005+22.68%$44.09$54.09
2006-15.00%$55.12$46.86
2007-32.11%$46.92$31.85
2008+23.93%$31.96$39.61
2009-4.10%$40.46$38.80
2010-4.89%$39.59$37.66
2011+16.79%$38.10$44.50
2012+37.04%$44.43$60.89
2013+30.34%$62.98$82.08
2014+40.22%$83.32$116.83
2015+3.57%$117.27$121.45
2016-5.23%$118.46$112.27
2017+18.60%$115.74$137.27
2018+13.21%$139.72$158.18
2019+29.44%$155.93$201.84
2020-1.59%$201.03$197.83
2021+2.32%$195.02$199.56
2022+19.52%$201.08$240.33
2023+13.89%$239.43$272.69
2024-9.71%$281.56$254.22
2025+29.42%$252.90$327.31

Historical annual returns for Amgen Inc.. Data shows year-over-year percentage change in stock price.

Why Use a "What If" Stock Calculator?

Many investors wonder questions such as:

A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.

Key Innovations

  • ✓Epogen (epoetin alfa), a recombinant protein that stimulates the production of red blood cells.
  • ✓Neupogen (filgrastim), a recombinant protein that stimulates the production of white blood cells.

Business Segments

  • Human Therapeutics
    Discovers, develops, manufactures, and delivers innovative human therapeutics.

How to Interpret the Results

The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can help investors understand risk, volatility, and growth potential.

For best use:

  • Compare multiple time ranges to see how outcomes differ
  • Use consistent assumptions across different stocks
  • Combine this tool with fundamental research and diversification principles

Explore Related Stocks in Tech

Popular in Other Sectors

finance:JPMBACV|healthcare:JNJUNHPFE|consumer:WMTDISNKE|etf:SPYQQQVOO|crypto:BTC-USDETH-USD|